Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Journal of Chemical Information and Computer Sciences|April 16, 1998
Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analoguesL M Shi, Y Fan, T G Myers, et al.American Journal of Human Genetics|March 1, 1995
Germ-line p53 mutations in 15 families with Li-Fraumeni syndromeT Frebourg, N Barbier, Y X Yan, et al.Proceedings of the National Academy of Sciences of the United States of America|July 15, 1992
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 proteinT Frebourg, J Kassel, K T Lam, et al.The EMBO Journal|February 28, 1998
Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpointsW A Cliby, C J Roberts, K A Cimprich, et al.Cancer Research|February 15, 1996
An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma linesI Bae, M L Smith, M S Sheikh, et al.Journal of Virology|March 1, 1990
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma proteinN Dyson, R Bernards, S H Friend, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutationsA L Børresen, E Hovig, B Smith-Sørensen, et al.Developmental Biology|September 1, 1992
Structure and expression of the Xenopus retinoblastoma geneO H Destrée, K T Lam, L J Peterson-Maduro, et al.Cell|August 10, 2000
Functional discovery via a compendium of expression profilesT R Hughes, M J Marton, A R Jones, et al.Cancer Research|February 10, 2000
Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiaeJ A Simon, P Szankasi, D K Nguyen, et al.Pageof 7